Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate

被引:141
作者
Safaiyan, F
Kolset, SO
Prydz, K
Gottfridsson, E
Lindahl, U
Salmivirta, M
机构
[1] Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden
[2] Univ Oslo, Inst Nutr Res, N-0316 Oslo, Norway
[3] Univ Oslo, Dept Biochem, N-0316 Oslo, Norway
关键词
D O I
10.1074/jbc.274.51.36267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have analyzed the effect of sodium chlorate treatment of Madin-Darby canine kidney cells on the structure of heparan sulfate (HS), to assess how the various sulfation reactions during HS biosynthesis are affected by decreased availability of the sulfate donor 3'-phosphoadenosine 5'-phosphosulfate. Metabolically [H-3]glucosamine-labeled HS was isolated from chlorate-treated and untreated Madin-Darby canine kidney cells and subjected to low pH nitrous acid cleavage. Saccharides representing (i) the N-sulfated domains, (ii) the domains of alternating N-acetylated and N-sulfated disaccharide units, and (iii) the N-acetylated domains were recovered and subjected to compositional disaccharide analysis. Upon treatment with 50 mM chlorate, overall O-sulfation of HS was inhibited by similar to 70%, whereas N-sulfation remained essentially unchanged. Low chlorate concentrations (5 or 2 mM) selectively reduced the 6-O-sulfation of HS, whereas treatment with 50 mM chlorate reduced both 2-O and 6-O-sulfation. Analysis of saccharides representing the different domain types indicated that 6-O-sulfation was preferentially inhibited in the alternating domains. These data suggest that reduced 3'-phosphoadenosine 5'-phosphosulfate availability has distinct effects on the N- and O-sulfation of HS and that O-sulfation is affected in a domain-specific fashion.
引用
收藏
页码:36267 / 36273
页数:7
相关论文
共 40 条
[31]  
PEJLER G, 1987, J BIOL CHEM, V262, P5036
[32]   Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4 [J].
Petersen, F ;
Brandt, E ;
Lindahl, U ;
Spillmann, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12376-12382
[33]   REQUIREMENT OF HEPARAN-SULFATE FOR BFGF-MEDIATED FIBROBLAST GROWTH AND MYOBLAST DIFFERENTIATION [J].
RAPRAEGER, AC ;
KRUFKA, A ;
OLWIN, BB .
SCIENCE, 1991, 252 (5013) :1705-1708
[34]   Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? [J].
Rosenberg, RD ;
Shworak, NW ;
Liu, J ;
Schwartz, JJ ;
Zhang, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2062-2070
[35]   Heparan sulfate: A piece of information [J].
Salmivirta, M ;
Lidholt, K ;
Lindahl, U .
FASEB JOURNAL, 1996, 10 (11) :1270-1279
[36]   Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells [J].
Salmivirta, M ;
Safaiyan, F ;
Prydz, K ;
Andresen, MS ;
ARyan, M ;
Kolset, SO .
GLYCOBIOLOGY, 1998, 8 (10) :1029-1036
[37]   FORMATION OF ANHYDROSUGARS IN CHEMICAL DEPOLYMERIZATION OF HEPARIN [J].
SHIVELY, JE ;
CONRAD, HE .
BIOCHEMISTRY, 1976, 15 (18) :3932-3942
[38]   Mouse mastocytoma cells synthesize undersulfated heparin and chondroitin sulfate in the presence of brefeldin A [J].
UhlinHansen, L ;
KuscheGullberg, M ;
Berg, E ;
Eriksson, I ;
Kjellen, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3200-3206
[39]  
WINTERBOURNE DJ, 1981, J BIOL CHEM, V256, P4310
[40]  
YANAGISHITA M, 1983, J BIOL CHEM, V258, P2857